CPAP in acute left ventricular failure

Date First Published:
September 28, 2000
Last Updated:
December 6, 2000
Report by:
Rupert Jackson, Specialist Registrar (MRI)
Search checked by:
Simon Carley, MRI
Three-Part Question:
[In patients with acute LVF] is [CPAP better than O2 via normal mask] at [avoiding intubation and improving mortality]?
Clinical Scenario:
A 76 year old male is brought in to A&E in a collapsed state. He has a history of ischaemic heart disease. He is agitated, tachypnoeic and sweating profusely. His neck veins are distended and there are widespread coarse crepitations in his chest. He has a diminished oxygen saturation. You make a clinical diagnosis of acute cardiogenic pulmonary oedema. In addition to vasodilator treatment and opiates, you wonder whether you should administer non-invasive continuous positive airways pressure (CPAP).
Search Strategy:
Medline 1966-09/00 using the OVID interface.
Search Details:
([exp pulmonary edema OR pulmonary oedema.mp OR exp ventricular dysfunction, left OR exp heart failure, congestive OR exp myocardial infarction OR left ventricular failure.mp OR LVF.mp) AND (exp positive-pressure respiration OR CPAP.mp OR continuous positive airway pressure$.mp OR PEEP.mp OR positive end expiratory pressure$.mp] AND maximally sensitive randomised controlled trial filter) LIMIT to human and english language
Outcome:
114 papers were found of which 109 were either irrelevant or of insufficient quality for inclusion. The remaining 5 papers are shown in the table.
Relevant Paper(s):
Study Title Patient Group Study type (level of evidence) Outcomes Key results Study Weaknesses
Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema Rasanen J, Heikkila J, Downs J,et al. 1985, Finland 40 patients with acute cardiogenic pulmonary oedema. RR > 25 and PaO2 < 200 mm Hg
CPAP (20) v control (20)
PRCT Need for intubation 6/20 v 12/20 (NS) Small numbers
Unblinded
Hospital mortality 17/20 v 14/20 deaths in hospital (NS)
Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. Bersten AD, Holt AW, Vedig AE, et al. 1991, Australia 39 patients with acute cardiogenic pulmonary oedema. PaO2 <70 mm Hg and PaCO2 >45 mm Hg
CPAP (19) v control (20)
PRCT Need for intubation 0/19 v 7/20 (p<0.005) Small numbers
Unblinded
Randomisation not concealed
Hospital mortality 2/19 v 4/20 (NS)
The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. Lin M, Chiang HT. 1991, Taiwan 55 patients with acute cardiogenic pulmonary oedema. RR>22
CPAP (25) v control (30)
PRCT Need for intubation 7/25 v 17/30 (p<0.05)
Hospital mortality 2/25 v 4/30 (NS)
Shunt size Significantly improved in CPAP group
PaO2 Significantly improved in CPAP group
Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Short-term results and long-term follow-up. Lin M, Yang YF, Chiang HT, et al. 1991, Taiwan 100 patients with a clinical diagnosis of acute cardiogenic pulmonary oedema
CPAP (50) v control (50)
PRCT Need for intubation 8/50 v 18/50 (P<0.01) Unblinded
Hospital mortality 4/50 v 6/50 (NS)
Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Takeda S, Nejima J, Takano T, et al. 1998, Japan 22 patients with acute cardiogenic pulmonary oedema. PaO2 <80 mm Hg
CPAP (11) v control (11)
PRCT Need for intubation 2/11 v 8/11 (P=0.03) Small numbers
Unblinded
hospital mortality 1/11 v 7/11 (P=0.02)
Author Commentary:
All of these trials have shown significant reductions in the need to intubate patients in acute pulmonary oedema. In these small trials a reduction in mortality could not be seen. The numbers in the trials are not large and there is not yet absolute evidence of benefit from CPAP. A large, well-designed PRCT may provide this. In the meantime it would appear that patients with severe LVF will benefit from CPAP.
Bottom Line:
Patients presenting with severe acute pulmonary oedema should be treated with continuous positive airway pressure (CPAP).
References:
  1. Rasanen J, Heikkila J, Downs J,et al.. Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema
  2. Bersten AD, Holt AW, Vedig AE, et al.. Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask.
  3. Lin M, Chiang HT.. The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema.
  4. Lin M, Yang YF, Chiang HT, et al.. Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Short-term results and long-term follow-up.
  5. Takeda S, Nejima J, Takano T, et al.. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction.